TP53 and lung cancer: A nationwide population-based study in Sweden including 83 non-smoking and 250 smoking-induced lung cancers investigated the association between TP53 mutations and time-weighted average radon concentrations of less than 50 Bq m−3 or greater than 140 Bq·m−3 adjusting for smoking status, age and gender [70].